Outcomes of transfemoral TAVR using two new-generation devices in patients with horizontal aorta.
Clemens EckelWon Keun KimBotros WasifChristina GrothusenAlbrecht ElsässerGuido DohmenEfstratios I CharitosSamuel SossallaHelge MöllmannJohannes BlumensteinPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
Transfemoral TAVR in patients with severe aortic stenosis and HA, using the balloon expandable Sapien3 Ultra and self-expanding ACURATE Neo2 prosthesis, is feasible and safe. Therefore, valve selection between these platforms should be made irrespective of the aortic angle by a team experienced with both valves based on their specific advantages. Large, randomized trials in this sub-group of patients would be necessary to compare long term outcomes.
Keyphrases
- aortic valve
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- end stage renal disease
- left ventricular
- newly diagnosed
- high resolution
- chronic kidney disease
- type diabetes
- palliative care
- skeletal muscle
- peritoneal dialysis
- prognostic factors
- early onset
- quality improvement
- drug induced
- pulmonary artery
- coronary artery